150
Participants
Start Date
January 31, 2024
Primary Completion Date
April 30, 2025
Study Completion Date
December 31, 2025
Decision Coach Sessions
"Participants in the intervention group and their families will be referred to the DC to meet independently and discuss recommended treatment pathways.~Multiple sessions may be necessary until a final decision is reached. All SDM consults will be done virtually using a secure videoconferencing platform. The Ottawa Family Decision Guide will be used to facilitate the discussion. A DA will be provided to the study participants in the form of information cards containing information about different treatment options in pediatric IBD. This includes administration schedule, side effects, risk of cancer, among others. The DA has been developed and provided by the Cincinnati Children's Hospital Medical Center and adapted to the Canadian setting with electronic version by this research group with approval from the authors."
Lead Sponsor
Children's Hospital Medical Center, Cincinnati
OTHER
London Health Sciences Centre
OTHER